Obermatt
See Similar Stocks →

Cardiol Therapeutics

TOR:CRDL · CA14161Y2006
PharmaceuticalsX-Small

360° View

81
Price/Sales5
Price/Earnings60
Price/Book86
Dividend Yield1
Revenue Growth—
Profit Growth50
Capital Growth100
TSR 52w23
Leverage100
Liquidity88
Refinancing18
Combined77
Analyst Opinions60
Pro Holdings9
Opinion Changes50
Market Pulse65

Profile

CountryCanada
IndustryPharmaceuticals
SizeX-Small
TypePublic Company
ExchangeTSX
Founded2017
Employees24
Websitecardiolrx.com
ISINCA14161Y2006
Last UpdateApr 2, 2026
Index & Theme
CannabisInflammationCardiovascularPain ManagementBiotechnologyLife ScienceNanotechnology

Description

Cardiol Therapeutics Inc. (‘Cardiol’), a clinical-stage life sciences company, focuses on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company’s lead small molecule drug candidate, CardiolRx (canna…

Analysis

Cardiol Therapeutics's 360° View rank of 81 places it among the strongest overall — better than 81% of its true peers.

It's growing solidly (63) and on the expensive side (43). On safety it is very well financed (84), and the market shows favorable sentiment (51). Taken together, its Combined rank of 77 reads as among the strongest overall.

360° rank · history

1007550250
81
2026

All-time high

96

Mar 2026

All-time low

81

Jun 2026

Average rank

89

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
5
—
—
—
Price/Earnings
60
—
—
—
Price/Book
86
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
43
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Cardiol Therapeutics with its peers
Lexicon Pharmaceuticals
NAQ:LXRX
28
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kura Oncology
NSQ:KURA
30
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Contineum Therapeutics
NSQ:CTNM
80
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Xeris Pharmaceuticals
NSQ:XERS
70
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
MannKind
NMQ:MNKD
24
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Village Farms International
NAQ:VFF
100
CountryCanada
IndustryFood Products
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →